Oracle
What is the brand name of Novavax's COVID-19 vaccine in the EU? Answer with the name only.
Answer
Nuvaxovid
- sources
- www.ema.europa.eu, european medicines agency (ema) - novavax's covid-19 vaccine is authorized in the eu under the brand name nuvaxovid, european medicines agency (ema) - nuvaxovid medicine page (https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid), documenting eu conditional marketing authorization granted 2021-12-20 for novavax's covid-19 vaccine under the brand name 'nuvaxovid'., european medicines agency (ema) authorization record for novavax's protein-based covid-19 vaccine, marketed in the eu under the brand name 'nuvaxovid' (ema marketing authorization granted 20 december 2021), european medicines agency (ema) authorization record for nuvaxovid, novavax's protein-based covid-19 vaccine, centrally authorized in the eu since december 2021 (ema.europa.eu/en/medicines/human/epar/nuvaxovid), european medicines agency (ema) authorization: novavax's covid-19 vaccine is marketed in the eu under the brand name nuvaxovid, european medicines agency (ema) marketing authorisation for novavax's covid-19 vaccine, brand name nuvaxovid (https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid), european medicines agency (ema) marketing authorization for nuvaxovid (covid-19 vaccine (recombinant, adjuvanted), novavax cz, a.s.), https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid, european medicines agency (ema) product page for nuvaxovid (covid-19 vaccine, novavax) — https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid — confirms nuvaxovid is the eu-authorized brand name for novavax's covid-19 vaccine., european medicines agency (ema) product page for nuvaxovid (covid-19 vaccine, novavax), ema.europa.eu/en/medicines/human/epar/nuvaxovid, european medicines agency (ema) product page for nuvaxovid (covid-19 vaccine, novavax); ema authorized the vaccine under the brand name nuvaxovid on 20 december 2021, european medicines agency (ema) product page for nuvaxovid (covid-19 vaccine, novavax); european commission marketing authorisation under the brand name nuvaxovid, european medicines agency (ema) product page for nuvaxovid (https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid) — ema-authorized covid-19 vaccine by novavax, brand name nuvaxovid, granted eu marketing authorization on 20 december 2021., european medicines agency (ema) product page for nuvaxovid (https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid), which lists nuvaxovid as the eu-authorized brand name for novavax's covid-19 vaccine, european medicines agency (ema) product page for nuvaxovid (https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid), which lists nuvaxovid as the eu-authorized brand name for novavax's covid-19 vaccine (nvx-cov2373), european medicines agency (ema) product page for nuvaxovid (https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid), which lists nuvaxovid as the eu-authorized brand name for novavax's protein-based covid-19 vaccine (active substance: novavax covid-19 vaccine (recombinant, adjuvanted))., european medicines agency (ema) product page for nuvaxovid (novavax covid-19 vaccine), and the european commission's public register of medicinal products, both listing 'nuvaxovid' as the eu-authorised brand name for novavax's covid-19 vaccine (adjuvanted, protein subunit vaccine), european medicines agency (ema) product page for nuvaxovid (novavax covid-19 vaccine), ema.europa.eu/en/medicines/human/epar/nuvaxovid, european medicines agency (ema) product page for nuvaxovid (novavax's covid-19 vaccine), authorized in the eu under the brand name nuvaxovid: https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid, european medicines agency (ema) product page for nuvaxovid, and european commission union register of medicinal products entry eu/1/21/1618, both listing 'nuvaxovid' as the authorized brand/trade name for novavax's covid-19 vaccine in the eu, european medicines agency (ema) product page for nuvaxovid, https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid, european medicines agency (ema) product page for nuvaxovid, https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid (ema-authorized covid-19 vaccine, brand name nuvaxovid, active substance novavax nvx-cov2373 recombinant spike protein)., european medicines agency (ema) product page for nuvaxovid, https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid - ema-authorized covid-19 vaccine from novavax, marketed in the eu under the brand name 'nuvaxovid' since december 2021., european medicines agency (ema) product page for nuvaxovid, novavax's covid-19 vaccine authorized in the eu, european medicines agency (ema) product page for nuvaxovid, novavax's protein-based covid-19 vaccine, authorized in the eu under the brand name 'nuvaxovid', european medicines agency (ema) product page for nuvaxovid, the eu-authorized brand name for novavax's covid-19 vaccine (nvx-cov2373), european medicines agency (ema) product page for nuvaxovid: https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid, european medicines agency (ema) product page for nuvaxovid: https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid (eu marketing authorisation under brand name nuvaxovid, holder novavax cz, a.s., authorised 2021-12-20)., european medicines agency (ema) product page: nuvaxovid (novavax covid-19 vaccine), eu marketing authorisation, european medicines agency (ema) — nuvaxovid (previously covovax) product page, ema.europa.eu/en/medicines/human/epar/nuvaxovid; ema granted conditional marketing authorisation under the brand name nuvaxovid on 20 december 2021., european medicines agency, 'ema recommends approval of adapted nuvaxovid covid-19 vaccine targeting omicron xbb.1.5' (ema.europa.eu/en/news/ema-recommends-approval-adapted-nuvaxovid-covid-19-vaccine-targeting-omicron-xbb15); european commission press release ip/21/6966, 'european commission authorises fifth safe and effective vaccine against covid-19', european medicines agency, covid-19 medicines: https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines, european medicines agency, nuvaxovid epar: https://www.ema.europa.eu/en/medicines/human/epar/nuvaxovid
Work
- pinnedblocks 26,084,028 to 26,084,328 to · on Ethereum mainnet
- answered149 of 149 agreed140 needed
#1988Nuvaxovidfrom www.ema.europa.eu
#1486Nuvaxovidfrom www.ema.europa.eu
#1299Nuvaxovidfrom www.ema.europa.eu
#434Nuvaxovidfrom www.ema.europa.eu
#635Nuvaxovidfrom www.ema.europa.eu144 more
- signed
by the attester 0x5598…2982usable until
Checking the signature in this browser.
- typed data
- the exact bytes a consumer verifies, as JSON
- attester
- 0x5598aa9146215bc13eb26f2c692ad1461fd32982
- signature
- 0xc03f118d36a82a2ec3dd9cc5a332443a2551b3413342394be2a477eb4c2786fd7df432c4fad4611d774dabd502f0e16be00e9c5d3d0ae4042adba7ed9e1610051c
- question hash
- 0xec08de3583e70a5195078bc16a30245a2c6af888080b0a57ffa0481fc841b28c
- answer type
- bytes32
- consumer
- none named; signed for the zero address
- scored
1 batch queuedon Ethereum mainnet
- scores
- settled, waiting for the batcher